Skip to main content
search
Main navigation
Home
About
About ACSH
Financials
Our Team
Donate
Publications
Media/Contact
Subscribe
Write For Us
drug approval
email
facebook
twitter
linkedin
pocket
reddit
print
Could Pressure for COVID-19 Drugs Lead FDA to Lower Its Standards?
By Leigh Turner, University of Minnesota
Read more
Forbes Features ACSH On New Hepatitis C Treatments
In Forbes, Dr. Josh Bloom, American Council on Science and Health Director of Chemical and Pharmaceutical Sciences, and Dr. Henry I.
Read more
Subscribe to drug approval
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
Fructose Causes Cancer in Lab Animals. What About People?
Smoke And Mirrors: Truth Initiative Conceals Benefits Of Vaping
A 'New' Sleep Aid From Cannabis ... If You Want to Be Up Half the Night
An ACSH Christmas Carol Dedicated to RFK Jr.
Dr. Kolodny’s New Math: Turning Chronic Pain Patients into OUD Statistics
ACSH Podcasts
Podcast: RFK, Jr. Poised to Run HHS. Public Health Apocalypse Imminent?
Podcast: Mayo Clinic's Nonsense Anti-Opioid Study
Podcast: Everything You Wanted to Know About NSAIDs
Podcast: Have We Lost the Battle Against Cardiovascular Disease?
Podcast: Prohibition Unhinged: How Rigid Drug Laws Cost a Drug-Free Trucker His Job
More podcasts
Latest from Henry
COVID Vaccination Mandates in Nursing Homes Improved Patient Outcomes
The Media and I: H5N1 'Bird Flu'
Should Paranoid Schizophrenics Be Air-Traffic Controllers?
The Media and I: Nominations to HHS, CMS, and NIH for Trump 2.0
More articles
Latest from Josh
The J-Man Chronicles: My Chatbot Really *Is* Human
Carbon-14 Dating of a Fruitcake: A Holiday Chemistry Lesson From Hell
Fructose Causes Cancer in Lab Animals. What About People?
An ACSH Christmas Carol Dedicated to RFK Jr.
More articles
Latest from Chuck
Hospital Gowns: Fashion Fail or Psychological Foe?
What I'm Reading (Dec. 19)
Living Longer, Not Healthier: The Growing Gap Between Lifespan and 'Healthspan'
Dr. Kolodny’s New Math: Turning Chronic Pain Patients into OUD Statistics
More articles